Pancreatic cancer patient symposium Feb. 9
Provides info on latest in research, treatment
Pancreatic cancer is the nation’s No. 4 cancer killer, but a diagnosis is not a death sentence, as research and new potential therapies provide hope for patients each day.
To educate on these latest breakthroughs as well as the spectrum of the illness, including screening, evaluation, personalized treatment approaches and survivorship care, the University of Cincinnati (UC) Cancer Institute is hosting an educational event for patients, survivors, their families and the community.
Cooper Creek Event and Conference Center
The event, being held from 1 p.m. to 4 p.m. Saturday, Feb. 9, at the Cooper Creek Event and Conference Center, 4040 Cooper Rd., Blue Ash, will involve presentations from experts within the institute at UC, the community, patients and more.
Talks will touch on symptom management, nutritional guidelines and the patient experience of living with and surviving pancreatic cancer. Additionally, attendees will hear from caregivers and family members of those with the disease and will have an opportunity to ask UC experts questions. UC Health’s Integrative Medicine will be on hand, as well, to offer tips on mindful relaxation techniques.
“We hope this event will help raise awareness about pancreas cancer in the community and highlight new, groundbreaking treatment strategies,” adds Sameer Patel, MD, assistant professor of surgery at the UC College of Medicine, UC Health surgical oncologist and a member of the UC Cancer Institute.
Light refreshments will be provided. For more information, contact Kelly Hummel at 513-558-2030.
Featured photo of Sameer Patel, MD / Credit: Tommy Campbell, UC Health
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.